Search results
Myriad Genetics director Daniel K. Spiegelman sells shares worth over $167k By Investing.com
Investing.com· 3 days agoDaniel K. Spiegelman, a director at Myriad Genetics Inc. (NASDAQ:MYGN), has sold a total of 7,576...
Insider Sale: Director Daniel Spiegelman Sells Shares of Myriad Genetics Inc (MYGN)
GuruFocus.com via Yahoo Finance· 3 days agoOver the past year, Daniel Spiegelman has sold a total of 7,576 shares and has not made any...
Myriad (MYGN) Down 5.2% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo Finance· 2 days agoIt has been about a month since the last earnings report for Myriad Genetics (MYGN). Shares have...
Insider Sale Alert: Myriad Genetics, Inc. [MYGN] – Is it Time to sell? – Knox Daily
Knox Daily· 4 days ago[NASDAQ:MYGN] saw its stock fall -1.80% to $22.35. Over the last five days, the stock has lost -3.50%. Myriad Genetics
Best Buy upgraded, Target initiated: Wall Street's top analyst calls
The Fly via Yahoo Finance· 5 days agoJefferies sees a host of headwinds for growth tools and awaits more visibility, and is upbeat on the...
QIAGEN's (QGEN) New Launch Expands US Syndromic Testing Menu
Zacks via Yahoo Finance· 3 days agoOther Developments in the Molecular Diagnostics Business Last week, QIAGEN, together with Myriad ...
What's Driving Twist Bioscience Corp's Surprising 15% Stock Rall
Guru Focus· 4 days agoTwist Bioscience Corp (TWST, Financial), a prominent player in the Medical Diagnostics & Research industry, has demonstrated a notable performance in the stock market recently ...
GenomeWeb Top 40 up 1 Percent in May, Though Gains Trail Broader Market
GenomeWeb News· 5 days agoThe Dow Jones Industrial Average rose 3 percent, the Nasdaq rose 7 percent, and the Nasdaq Biotech Index rose 6 percent.